PharmacoEconomics

New Prescription for the Spanish Drug Sector: Fighting against Public Deficit without Wasting Ammunition
pp. 977-980(4)
Authors: Antoñanzas, Fernando; Gómez, Pedro

Evaluation of Benefit-Risk
pp. 981-986(6)
Author: Garattini, Silvio

An Analysis of NICE's `Restricted' (or `Optimized') Decisions
pp. 987-993(7)
Authors: O'Neill, Phill; Devlin, Nancy J.

Methods of Model Calibration: Observations from a Mathematical Model of Cervical Cancer
pp. 995-1000(6)
Authors: Taylor, Douglas C.A.; Pawar, Vivek; Kruzikas, Denise; Gilmore, Kristen E.; Pandya, Ankur; Iskandar, Rowan; Weinstein, Milton C.

Cost Effectiveness of Pharmacogenomics: A Critical and Systematic Review
pp. 1001-1013(13)
Authors: Wong, William B.; Carlson, Josh J.; Thariani, Rahber; Veenstra, David L.

Economic Implications of Sleep Disorders
pp. 1015-1023(9)
Authors: Skaer, Tracy L.; Sclar, David A.

Economic Efficiency of Genetic Screening to Inform the Use of Abacavir Sulfate in the Treatment of HIV
pp. 1025-1039(15)
Authors: Kauf, Teresa L.; Farkouh, Raymond A.; Earnshaw, Stephanie R.; Watson, Maria E.; Maroudas, Penny; Chambers, Mike G.

Economic Evaluation of Cinacalcet in the Treatment of Secondary Hyperparathyroidism in Italy
pp. 1041-1054(14)
Authors: Eandi, Mario; Pradelli, Lorenzo; Iannazzo, Sergio; Chiroli, Silvia; Pontoriero, Giuseppe

Cost Effectiveness of Imiquimod 5% Cream Compared with Methyl Aminolevulinate-Based Photodynamic Therapy in the Treatment of Non-Hyperkeratotic, Non-Hypertrophic Actinic (Solar) Keratoses: A Decision Tree Model
pp. 1055-1064(10)
Author: Wilson, Edward C.F.